FenXun Partners
We only have limited information for this firm. Consider the following firms which have provided more information:
FenXun Partners is particularly recommended for handling patent infringement and enforcement litigation in the PRC life sciences space. As the joint operation partner of Baker McKenzie FenXun, the firm regularly assists large multinational pharmaceutical corporations on their China operations and advises foreign research and development companies on acquisitions in the PRC market. Practice head Vivian Wu and Hong Zhang are the key names to note.
Legal 500 Editorial commentary
Key clients
- Boston Scientific Corporation
- Chugai Pharma
Abbreviated data is displayed for this firm.
Work highlights
- Advised Boston Scientific Corporation on the acquisition of 65% in Acotec Scientific Holdings Limited through a voluntary conditional partial cash offer.
- Advised Chugai Pharma on overall enforcement strategy and represented them in a patent linkage action in China.
Abbreviated data is displayed for this firm.